{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:22:00Z","timestamp":1777562520467,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.medcli.2018.04.020","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T13:05:31Z","timestamp":1528290331000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impacto de la bacteriemia por Pseudomonas aeruginosa en un hospital de tercer nivel: mortalidad y factores pron\u00f3sticos"],"prefix":"10.1016","volume":"152","author":[{"given":"Alejandro","family":"Callejas-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ramos-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"M\u00fa\u00f1ez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"S\u00e1nchez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Vargas N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2018.04.020_bib0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/jhin.2002.1370","article-title":"Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit","volume":"53","author":"Thuong","year":"2003","journal-title":"J Hosp Infect."},{"key":"10.1016\/j.medcli.2018.04.020_bib0160","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012 [consultado 19 Dic 2017]. Disponible en: https:\/\/ecdc.europa.eu\/en\/publications-data\/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use-0"},{"key":"10.1016\/j.medcli.2018.04.020_bib0165","unstructured":"Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica e Higiene. European Centre for Disease Prevention and Control. Estudio de Prevalencia de las Infecciones Nosocomiales en Espa\u00f1a: Informe Global EPINE-EPPS 2015 [consultado 19 Dic 2017]. Disponible en: http:\/\/hws.vhebron.net\/epine\/"},{"key":"10.1016\/j.medcli.2018.04.020_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2334-14-161","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0175","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/AAC.02467-12","article-title":"Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa","volume":"57","author":"Hattemer","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.medcli.2018.04.020_bib0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: A post hoc analysis of a prospective cohort","volume":"57","author":"Pe\u00f1a","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diagmicrobio.2011.09.018","article-title":"A model to predict mortality following Pseudomonas aeruginosa bacteremia","volume":"72","author":"Hirsch","year":"2012","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2011.05.010","article-title":"Pseudomonas aeruginosa bacteremia upon hospital admission: Risk factors for mortality and influence of inadequate empirical antimicrobial therapy","volume":"71","author":"Schechner","year":"2011","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s15010-011-0124-6","article-title":"Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: A stratified analysis according to sites of infection","volume":"39","author":"Joo","year":"2011","journal-title":"Infection."},{"key":"10.1016\/j.medcli.2018.04.020_bib0200","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10096-008-0568-5","article-title":"Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia","volume":"27","author":"Cheong","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.diagmicrobio.2016.10.008","article-title":"Tree-structured survival analysis of patients with Pseudomonas aeruginosa bacteremia: A multicenter observational cohort study","volume":"87","author":"Yoon","year":"2017","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0215","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10096-017-2907-x","article-title":"Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: A retrospective cohort study","volume":"36","author":"Paulsson","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.medcli.2018.04.020_bib0225","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/596709","article-title":"Gram-negative bacteremia upon hospital admission: When should Pseudomonas aeruginosa be suspected?","volume":"48","author":"Schechner","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0230","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjmed.2008.03.034","article-title":"Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia","volume":"121","author":"Cheong","year":"2008","journal-title":"Am J Med."},{"key":"10.1016\/j.medcli.2018.04.020_bib0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s15010-009-9145-9","article-title":"Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection","volume":"38","author":"Parkins","year":"2010","journal-title":"Infection."},{"key":"10.1016\/j.medcli.2018.04.020_bib0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1469-0691.2005.01102.x","article-title":"Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia","volume":"11","author":"Kang","year":"2005","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.medcli.2018.04.020_bib0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2334-12-56","article-title":"An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis","volume":"12","author":"Micek","year":"2012","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0250","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 [consultado 19 Dic 2017]. Disponible en: https:\/\/ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2014"},{"key":"10.1016\/j.medcli.2018.04.020_bib0255","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.ijid.2009.11.019","article-title":"Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection","volume":"14","author":"Suarez","year":"2010","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0260","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.05991-11","article-title":"Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections","volume":"56","author":"Pe\u00f1a","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.medcli.2018.04.020_bib0265","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/jmm.0.073262-0","article-title":"Pseudomonas aeruginosa bacteraemia: Independent risk factors for mortality and impact of resistance on outcome","volume":"63","author":"Dantas","year":"2014","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.medcli.2018.04.020_bib0270","doi-asserted-by":"crossref","first-page":"e26470","DOI":"10.1371\/journal.pone.0026470","article-title":"Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia","volume":"6","author":"Bliziotis","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2018.04.020_bib0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2009.02.006","article-title":"Morbidity associated with Pseudomonas aeruginosa bloodstream infections","volume":"64","author":"Scheetz","year":"2009","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhin.2016.11.014","article-title":"Long-term mortality following Pseudomonas aeruginosa bloodstream infection","volume":"95","author":"McCarthy","year":"2017","journal-title":"J Hosp Infect."},{"key":"10.1016\/j.medcli.2018.04.020_bib0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7883\/yoken.JJID.2014.573","article-title":"Pseudomonas aeruginosa bacteremia among immunocompetent and immunocompromised patients: Relation to initial antibiotic therapy and survival","volume":"69","author":"Migiyama","year":"2016","journal-title":"Jpn J Infect Dis."},{"key":"10.1016\/j.medcli.2018.04.020_bib0290","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.medcli.2018.04.020_bib0295","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2012.12.006","article-title":"Beta-lactam plus aminoglycoside or fluoroquinolone combination versus beta-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis","volume":"41","author":"Vardakas","year":"2013","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.medcli.2018.04.020_bib0300","first-page":"58","article-title":"[Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia]","volume":"34","author":"Gonzalez","year":"2014","journal-title":"Biomedica."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318302963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318302963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T04:57:15Z","timestamp":1548392235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775318302963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0025775318302963"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2018.04.020","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacto de la bacteriemia por Pseudomonas aeruginosa en un hospital de tercer nivel: mortalidad y factores pron\u00f3sticos","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2018.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}